Methamphetamine treatment has no approved medication yet
Methamphetamine is a stimulant that can cause a severe substance use disorder and affect sleep, nutrition, mood, cognition, cardiovascular health, and behavior. Treatment intensity should reflect current use, psychosis or suicide risk, medical problems, housing, other substances, and the person's ability to attend care safely. Research on medications continues, but programs should not describe an unapproved product as established treatment. Behavioral care remains central, with contingency management having the strongest current support and other therapies helping address skills, motivation, and co-occurring needs.
Meaningful incentives require a real protocol
No medication is currently FDA approved specifically for methamphetamine use disorder. NIDA identifies contingency management as the most effective established behavioral treatment, while research continues on medications and combinations that may help selected patients under clinical supervision. Effective contingency management defines the target, checks it frequently, and provides prompt rewards of sufficient value. Ask for the schedule, duration, maximum possible amount, and evidence behind the model rather than accepting a vague promise of prizes.
Early care often focuses on sleep and stabilization
Care may combine contingency management, cognitive behavioral therapy, motivational approaches, individual and group treatment, recovery support, sleep and nutrition care, and help with housing or employment. Clinicians should assess for depression, anxiety, trauma, psychosis, attention problems, and opioid exposure rather than assuming every symptom has one cause. After prolonged use, a person may experience exhaustion, low mood, strong appetite changes, anxiety, or difficulty thinking clearly. Regular food, hydration, quiet sleep, medical review, and psychiatric monitoring can support participation while the treatment plan develops.
Psychosis and overheating need urgent attention
Methamphetamine can contribute to overheating, chest pain, stroke, seizures, severe agitation, paranoia, hallucinations, and suicidal behavior. Call 911 for collapse, chest pain, a seizure, severe confusion, extreme temperature, trouble breathing, or an immediate risk of harm, and avoid escalating a frightened or paranoid person. Paranoia, hallucinations, severe agitation, chest pain, seizure, very high temperature, or suicidal behavior can become dangerous quickly. Reduce stimulation, avoid arguing with frightening beliefs, call 911, and tell responders about possible stimulant and other drug exposure.
Other substances can change the plan
Ask whether the program provides real contingency management with defined targets and meaningful incentives, not merely a rewards-themed activity. Confirm access to medical and psychiatric care, how psychosis is managed, whether naloxone is provided, and how the plan addresses other substances and long gaps in sleep. Opioids, alcohol, benzodiazepines, nicotine, and cannabis may be used alongside methamphetamine or to manage its aftereffects. The program should assess and treat those patterns, provide naloxone, and avoid assuming every symptom comes from one drug.
Recovery planning should be concrete and immediate
Seek an assessment promptly, especially after psychosis, a medical emergency, suicidal thinking, or repeated inability to stop. Build a practical plan for sleep, food, hydration, transportation, drug-free contacts, high-risk places, and rapid return to care after any renewed use. Long-term promises are less useful than a schedule for the next day and week covering sleep, meals, appointments, transportation, money, and safe contacts. Identify high-risk people and places and make re-entry easy if the patient misses care or uses again.
Expect concentration and motivation to recover unevenly
Thinking, pleasure, sleep, and energy may remain disrupted after acute intoxication ends, and the timeline differs across people. Programs should set achievable tasks, repeat information, and avoid interpreting every difficulty as defiance. Persistent depression, psychosis, or cognitive problems need clinical reassessment. Progress can be measured through attendance, safer choices, sleep, health, relationships, and functioning while the longer recovery process continues.